Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning

28 Aug 2024

Abstract excerpt

BACKGROUND: Pancreatic cancer is often diagnosed at advanced stages, and early-stage diagnosis of pancreatic cancer is difficult because of nonspecific symptoms and lack of available biomarkers. METHODS: We performed comprehensive serum miRNA sequencing of 212 pancreatic cancer patient samples from 14 hospitals and 213 non-cancerous healthy control samples. We randomly classified the pancreatic cancer and control...

Topics

Join the communities discussing this publication.

Gene expression and cancer classification
MicroRNA in disease regulation
Pancreatic and Hepatic Oncology Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39198617
DOI: 10.1038/s41416-024-02794-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learningPMID 39198617Read ↗

Early detection of pancreatic cancer: Where are we now and where are we going?Semantic proximity Read ↗

Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancerSemantic proximity Read ↗

Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methodsSemantic proximity Read ↗

Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAsSemantic proximity Read ↗

Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based VariantsSemantic proximity Read ↗

Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithmsSemantic proximity Read ↗

Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithmsSemantic proximity Read ↗

Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter studySemantic proximity Read ↗

MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease ControlsSemantic proximity Read ↗

Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From ControlsSemantic proximity Read ↗

A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control studySemantic proximity Read ↗

Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas DataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.